日本允许OTC在药剂师的指导下从2025年10月20日起出售紧急避孕药Norlevo。 Japan allows OTC sale of emergency contraceptive Norlevo, effective Oct 20, 2025, with pharmacist guidance.

日本已经批准从2025年10月20日起在场外出售紧急避孕药Norlevo,这是日本首次在没有处方的情况下提供这种药片。 Japan has approved the over-the-counter sale of the emergency contraceptive Norlevo, the first such pill available without a prescription in the country, starting Oct 20, 2025. 由Aska制药公司生产的药物必须当着药剂师的面配发,因为它被归类为“需要指导的药物”。 年龄限制或父母同意都无须。 The drug, made by Aska Pharmaceutical, must be dispensed in the presence of a pharmacist due to its classification as “medicine requiring guidance.” No age limits or parental consent are required. 它在无保护性行为72小时之内有效,效果大约80%。 It is effective within 72 hours of unprotected sex, with about 80% efficacy. 这一行动是在宣传努力和2023年试点方案之后进行的,使日本与90多个国家和世卫组织关于获得生殖健康的建议保持一致。 The move follows advocacy efforts and a 2023 pilot program, aligning Japan with over 90 countries and WHO recommendations on reproductive health access.